ANTIHYPERGLYCEMIC MEDICATION PRESCRIBING AND STATE MEDICAID PROGRAM RESPONSES TO ROSIGLITAZONE SAFETY WARNINGS

Medicaid programs use preferred drug lists to limit high-cost prescribing, but their effect on promoting more effective and safer prescribing is unknown. We examined the impact of the May 2007 rosiglitazone safety warnings on rosiglitazone availability on state Medicaid preferred drug list programs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ross, Joseph S., Jackevicius, Cynthia A., Krumholz, Harlan M., Ridgeway, Jennifer L., Montori, Victor M., Alexander, G. Caleb, Zerzan, Judy T., Fan, Jiaquan, Shah, Nilay D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319744/
https://ncbi.nlm.nih.gov/pubmed/22232110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.2011.1068
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares